Xcout Intel
Be Biopharma
Be Biopharma is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing engineered B cell therapies.
Subscribe to see Be Biopharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Be Biopharma at a glance
Be Biopharma is a biotechnology company headquartered in United States. It has raised at least $144M across the 2 funding rounds on record. Its most recent funding round, Series C, raised $92M in January 2025. Xcout tracks 3 named people at Be Biopharma, including David Rawlings (co-founder).
Be Biopharma leadership
- David Rawlingsco-founder
- Lea Hachigianfounder
- Richard Jamesco-founder
Be Biopharma funding rounds
At least $144M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $92M | — | |
| Series A | $52M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Be Biopharma competitors
A few of Be Biopharma's closest competitors — see the full list of competitors and alternatives →
Beigene, now known as BeOne Medicines, is a multinational oncology company. It specializes in biotechnology research and the development of cancer treatment drugs, with headquarters located in Cambridge, Massachusetts.
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Bellicum Pharmaceuticals, Inc. is a company focused on engineering high-performance cellular immunotherapies. These therapies are developed to combat diseases.
Boston Immune Technologies and Therapeutics, Inc. (BITT) is a company headquartered in Winchester, Massachusetts, that specializes in the development of cancer treatments and therapeutics.
Walking Fish Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on engineering B cell-based protein factories to develop novel biotherapeutics for treating serious diseases.
Get Be Biopharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Be Biopharma in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access